PHARMACIE DE FRONTENAY

PHARMACIE DE FRONTENAY

SIREN 524471448

Active

What the register says about PHARMACIE DE FRONTENAY

PHARMACIE DE FRONTENAY is registered under SIREN number 524471448. Its registered office is located at 1 Rue du Docteur Jean Debegue, 79270 Frontenay-Rohan-Rohan. The company was founded on 23/08/2010. It declares that it operates in the Commerce de détail de produits pharmaceutiques en magasin spécialisé sector. It is currently listed as active in the national business register.

BODACC has published 19 notices concerning it, the most recent dated 07/05/2026. An account filing makes public the annual accounts submitted to the court registry: it confirms that accounting records exist and have been filed, nothing more. It says nothing about revenue, profit, or the commercial health of the company. A modification signals a declared change: management, registered office, activity, or share capital.

Identity : PHARMACIE DE FRONTENAY

PHARMACIE DE FRONTENAY

SIREN
524471448
Head office SIRET
52447144800026
Legal form
5785
NAF code
47.73Z · Commerce de détail de produits pharmaceutiques en magasin spécialisé
Address
1 Rue du Docteur Jean Debegue, 79270 Frontenay-Rohan-Rohan
Creation date
08/23/2010
Category
PME
Status
Active
VAT
FR54524471448
Filing
05/07/2026
Closing
12/31/2025

Recent notices (19)

All legal notices

Web presence : PHARMACIE DE FRONTENAY

The company's official website, its networks and online contact details.

Recent notices : PHARMACIE DE FRONTENAY

The BODACC notices published for this company.

Relations : PHARMACIE DE FRONTENAY

The relationship graph: linked notices, people and companies.

Public contracts : PHARMACIE DE FRONTENAY

The public contracts won by the company.

No won public contract found for this company

FAQ & filings : PHARMACIE DE FRONTENAY

Frequently asked questions and the company's filing history.

Frequently asked questions : PHARMACIE DE FRONTENAY

Deposit filing history

11 dépôts de comptes enregistrés au BODACC — dernier exercice clos le 12/31/2025.